文献速递消化与肝胆胰病理细胞病理与分子病理

肝细胞腺瘤瘤间异质性:亚型分布与临床意义

Identification and relevance of inter‐tumour heterogeneity in hepatocellular adenoma according to subtypes and the context
RSS 订阅 · Histopathology · 2026-10-22

该研究描述了26例肝细胞腺瘤瘤间异质性(ITH-HCA)患者,多数由免疫组化及分子分析确定亚型。ITH-HCA覆盖全部HCA亚型,最常见为炎症型HCA合并其他亚型;男性多伴基础肝病。识别有恶变风险的b-HCA/b-IHCA外显子3及出血风险的sh-HCA需经验,建议转诊至三级中心。

要点

  • ITH-HCA指同一患者存在≥2个不同分子亚型HCA结节,临床罕见。
  • 女性多无基础肝病,男性多伴血管性或遗传性肝病。
  • b-HCA/b-IHCA外显子3有恶变风险,sh-HCA有出血风险,建议转诊三级中心。

核心结论

  • ITH-HCA覆盖HCA全部分类谱系,虽罕见但临床挑战大,尤其需识别恶变或出血风险病变。
  • 建议将ITH-HCA患者转诊至专科三级中心。

研究设计与样本

  • 回顾性系列研究,共纳入26例ITH-HCA患者,其中17例为女性。
  • 病例多数来自波尔多,另有国际中心贡献病例;亚型经免疫组化确定,多数经分子分析证实。

主要发现

  • 26例中17例女性;女性均无基础肝病,男性9例中8例有基础肝病。
  • 最大亚组为22例IHCA合并另一亚型:H-HCA 5例,H-HCA与b-IHCA外显子3交界1例,b-IHCA外显子3 6例,b-HCA与b-IHCA外显子3 4例,b-IHCA外显子7/8 2例,sh-HCA 3例,UHCA 1例。
  • 其余4例中,sh-HCA合并UHCA 1例、合并b-IHCA外显子3 1例;2例为HNF1A腺瘤病,其中1例恶变,另1例伴b-IHCA外显子3进展为HCC。
  • 最大结节为13 cm的IHCA;1例sh-HCA表现为出血。

关键数值与推荐

  • ITH-HCA亚型包括H-HCA、IHCA、b-HCA(外显子3或7/8)、b-IHCA(外显子3或7/8)、sh-HCA和UHCA。
  • b-HCA或b-IHCA外显子3有恶变风险,sh-HCA有出血风险,识别需经验并建议转诊三级中心。

临床怎么用

  • 病理医生对正常肝背景的多数ITH-HCA可相对容易诊断,但IHCA合并b-IHCA外显子3及sh-HCA需经验。
  • 对怀疑ITH-HCA者应结合免疫组化及分子分析明确各结节亚型。
  • 识别b-HCA/b-IHCA外显子3(恶变风险)和sh-HCA(出血风险)并建议转诊专科中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with inter-tumour heterogeneity in hepatocellular adenoma (ITH-HCA) harbour 2 or more nodules of different molecular subtypes. ITH is rare, occurring mainly in women with no specific background disease; in men, ITH is observed essentially in patients with vascular or genetic liver diseases. The largest subgroup corresponded to IHCA combined with another subtype: H-HCA, b-IHCA/b-HCA exon 3, b-IHCA ex 7/8, sh-HCA or UHCA. The practicing pathologist can relatively easily diagnose the majority of ITH occurring on normal liver, to the exception of IHCA/ b-IHCA exon 3, a subtype at risk of malignant transformation and sh-HCA at risk of bleeding, both requiring experience; referral to a special tertiary centre is recommended. Introduction Different molecular subtypes of hepatocellular adenoma (HCA) can occur at the same time within the same patient, defining inter-tumour heterogeneity (ITH). We describe a series of HCA-ITH cases, most identified in Bordeaux with additional cases contributed by other international centres. Methods ITH-HCA cases were subtyped by immunohistochemistry, confirmed by molecular analysis in most cases. The resulting diagnoses were HNF1A-HCA (H-HCA), inflammatory HCA (IHCA), b-catenin-mutated HCA (b-HCA) involving exon 3 or 7/8, b-catenin-mutated IHCA (b-IHCA) involving exon 3 or 7/8, sonic hedgehog HCA (sh-HCA) and unclassified HCA (UHCA). Results We identified 26 patients with ITH-HCA including 17 women; none had underlying liver disease, whereas most men did (8/9). The largest subgroup comprised 22 patients with IHCA combined with another subtype: H-HCA (five patients); H-HCA and b-IHCA-exon 3 borderline (one patient); b-IHCA-exon 3 (six patients); b-HCA and b-IHCA exon 3 (four patients); b-IHCA-exon7/8 (two patients); sh-HCA (three patients); UHCA (one patient). The remaining four patients had sh-HCA combined with UHCA (one patient) or b-IHCA ex3 (one patient), and 2 patients with HNF1A adenomatoses, one with malignant transformation, the other associated with a b-IHCA exon3 progressed to HCC. The largest nodule was a 13 cm IHCA. One of the sh-HCA presented with bleeding. Conclusion ITH-HCA covers the whole spectrum of the HCA classification. It is rare but poses significant clinical challenges, particularly in terms of identifying those lesions at risk of malignant transformation (b-HCA or b-IHCA exon 3) or bleeding (sh-HCA). Referral to a special tertiary centre is recommended.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Histopathology:Identification and relevance of inter‐tumour heterogeneity in hepatocellular adenoma according to subtypes and the context

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。